RiceBran Technologies: management transactions · United States · SEC (Form 4)

About RiceBran Technologies

RiceBran Technologies (ticker: RIBT) is a United States-based issuer that was historically quoted on the NASDAQ and is now referenced in recent SEC-related materials as trading on the OTC Pink market following its delisting. The company is headquartered in Tomball, Texas, United States. It was incorporated in 2000 under the name NutraCea and adopted the RiceBran Technologies name in 2012, reflecting its original focus on rice bran valorization and its broader strategy around specialty grain ingredients. ([sec.gov](https://www.sec.gov/Archives/edgar/data/1063537/000143774924010135/ribt20231231_10k.htm?utm_source=openai)) RiceBran Technologies has been positioned as a specialty ingredient company focused on the development, production, and marketing of products derived from traditional and ancient small grains. Historically, its core platform centered on stabilized rice bran (SRB) and downstream derivatives. Its branded portfolio has included RiBalance, RiSolubles, RiFiber, and ProRyza, products designed for use in bakery applications, cereals, coatings, functional foods, high-end animal nutrition, and animal health. Management has described these offerings as natural, non-GMO, and gluten-free ingredients, supported by proprietary processing methods intended to improve nutrition, usability, and shelf life. ([sec.gov](https://www.sec.gov/Archives/edgar/data/1063537/000143774923006914/ribt20221231_10k.htm?utm_source=openai)) Operationally, the company once maintained a multi-site processing footprint across California, Louisiana, Montana, Arkansas, and Texas. That footprint has been dramatically reduced. In 2023, RiceBran Technologies completed the sale of its SRB-related business assets. In January 2024, it sold the Golden Ridge rice mill in Wynne, Arkansas. Later in 2024, the company disclosed that assets had been transferred to Funicular Funds after a foreclosure sale, underscoring a major restructuring of the balance sheet and operating base. For investors, these transactions are central because they show that the company has been in active asset-monetization and survival mode rather than in expansion mode. ([sec.gov](https://www.sec.gov/Archives/edgar/data/1063537/000143774924010135/ribt20231231_10k.htm?utm_source=openai)) From a competitive standpoint, the business has operated in a niche corner of the food ingredients industry where differentiation depends on proprietary processing, ingredient functionality, and the ability to create value from agricultural by-products. In prior filings, the company emphasized a competitive edge from decades of application know-how and proprietary methods. That said, the recent shrinkage of the operating platform materially changes how the competitive story should be assessed: RIBT is no longer a straightforward specialty ingredients growth story, but rather a distressed, restructured microcap with a much narrower business scope. ([sec.gov](https://www.sec.gov/Archives/edgar/data/1063537/000143774922006591/ribt20211231_10k.htm?utm_source=openai)) For French, Belgian, and Swiss investors, the key takeaway is that RIBT should be analyzed primarily through a restructuring lens. The most recent milestones include the sale of the stabilized rice bran business, the divestiture of the Arkansas mill, and the later transfer of assets to a lender-related buyer in 2024. Those events materially reduce operating visibility and highlight execution, financing, and going-concern risk. In practical terms, the investment case is driven less by product breadth or market share and more by the remaining asset base, the liquidation/reorganization path, and the optionality embedded in the public shell. ([sec.gov](https://www.sec.gov/Archives/edgar/data/1063537/000143774924010135/ribt20231231_10k.htm?utm_source=openai))